Label Image (Lbl530024730)
Montelukast Sodium
Product Images NDC 53002-4730
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 53002-4730). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Montelukast-fig1.jpg (Montelukast Fig1)
The text describes Figure 1 which displays the change in height in centimeters from the baseline visit over different weeks on treatment for three groups - nontelukast 5 mg, beclomethasone 336 µg, and placebo. The standard errors of the treatment group means in change in height are too small to be visible on the plot.*
Montelukast-fig2.jpg (Montelukast Fig2)
This is a graph (Figure 2) that shows the mean percent change from baseline in forced expiratory volume (FEV) in a clinical trial conducted in the United States. The trial participants were divided into two groups- one group was given Montelukast Sodium while the other group was given a placebo. The graph shows the percent change in FEV for both groups over 15 weeks of treatment and a washout period. The horizontal axis represents the weeks of treatment, while the vertical axis represents the mean percent change from baseline. The trial involved 406 individuals who were given Montelukast Sodium and 270 individuals who were given a placebo.*
Chemical Structure (Montelukast Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
